Table 5.

Medication intake from day 1 to 5 of participation.

Medication		Day 1, n (%)			Day 2, n (%)			Day 3, n (%)			Day 4, n (%)			Day 5, n (%)
		Control (n=51)	Endocare (n=51)	Control (n=50)		Endocare (n=49)	Control (n=32)		Endocare (n=37)	Control (n=23)		Endocare (n=29)	Control (n=22)		Endocare (n=20)
Analgesics
	Anilides	15 (29.4)	12 (23.5)	13 (26.0)		9 (18.4)	9 (28.1)		10 (27.0)	6 (26.1)		4 (13.8)	5 (22.7)		3 (15.0)
	Natural opium alkaloids	0 (0.0)	2 (3.9)	1 (2.0)		2 (4.1)	0 (0.0)		2 (5.4)	0 (0.0)		1 (3.4)	0 (0.0)		1 (5.0)
	Opioids in combination with antispasmodics	0 (0.0)	2 (3.9)	0 (0.0)		1 (2.0)	0 (0.0)		1 (2.7)	0 (0.0)		1 (3.4)	0 (0.0)		1 (5.0)
	Opioids in combination with nonopioid analgesics	3 (5.9)	3 (5.9)	3 (6.0)		2 (4.1)	1 (3.1)		1 (2.7)	2 (8.7)		1 (3.4)	2 (9.1)		1 (5.0)
	Other analgesics and antipyretics	2 (3.9)	7 (13.7)	6 (12.0)		4 (8.2)	1 (3.1)		3 (8.1)	1 (4.3)		2 (6.9)	1 (4.5)		2 (10.0)
	Other opioids	1 (2.0)	3 (5.9)	2 (4.0)		2 (4.1)	2 (6.2)		2 (5.4)	1 (4.3)		2 (6.9)	1 (4.5)		2 (10.0)
	Salicylic acid and derivatives	0 (0.0)	0 (0.0)	0 (0.0)		0 (0.0)	0 (0.0)		0 (0.0)	0 (0.0)		0 (0.0)	0 (0.0)		0 (0.0)
Other antiemetics and antinauseants		0 (0.0)	0 (0.0)	0 (0.0)		0 (0.0)	0 (0.0)		0 (0.0)	0 (0.0)		0 (0.0)	0 (0.0)		0 (0.0)
Other antiepileptics		0 (0.0)	0 (0.0)	0 (0.0)		0 (0.0)	0 (0.0)		0 (0.0)	0 (0.0)		0 (0.0)	0 (0.0)		0 (0.0)
Anti-inflammatory and antirheumatic products
	Fenamates	0 (0.0)	0 (0.0)	0 (0.0)		0 (0.0)	0 (0.0)		0 (0.0)	0 (0.0)		1 (3.4)	0 (0.0)		0 (0.0)
	Propionic acid derivates	10 (19.6)	13 (25.5)	9 (18.0)		12 (24.5)	8 (25.0)		8 (21.6)	3 (13.0)		9 (31.0)	5 (22.7)		3 (15.0)
Proton pump inhibitors (for acid-related disorders)		0 (0.0)	0 (0.0)	0 (0.0)		0 (0.0)	0 (0.0)		0 (0.0)	1 (4.3)		0 (0.0)	1 (4.5)		0 (0.0)
Other drugs for functional gastrointestinal disorders		4 (7.8)	4 (7.8)	4 (8.0)		2 (4.1)	3 (9.4)		1 (2.7)	1 (4.3)		1 (3.4)	3 (13.6)		1 (5.0)